Last reviewed · How we verify
Aesculus hippocastanum, and associations
Aesculus hippocastanum, and associations is a Herbal extract / Phlebotonic agent Small molecule drug developed by Fundação Educacional Serra dos Órgãos. It is currently FDA-approved for Chronic venous insufficiency, Varicose veins, Hemorrhoids. Also known as: no other intervention names.
Aesculus hippocastanum (horse chestnut seed extract) reduces inflammation and improves venous tone through its active constituent aescin, which stabilizes capillary membranes and reduces vascular permeability.
Aesculus hippocastanum (horse chestnut seed extract) reduces inflammation and improves venous tone through its active constituent aescin, which stabilizes capillary membranes and reduces vascular permeability. Used for Chronic venous insufficiency, Varicose veins, Hemorrhoids.
At a glance
| Generic name | Aesculus hippocastanum, and associations |
|---|---|
| Also known as | no other intervention names |
| Sponsor | Fundação Educacional Serra dos Órgãos |
| Drug class | Herbal extract / Phlebotonic agent |
| Target | Aescin (triterpene saponin); non-specific vascular and anti-inflammatory targets |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular / Vascular disorders |
| Phase | FDA-approved |
Mechanism of action
The extract contains aescin, a triterpene saponin that decreases inflammatory mediator release and strengthens the integrity of blood vessel walls. This mechanism reduces edema and improves blood flow in venous insufficiency. The compound also has antioxidant properties that contribute to its anti-inflammatory effects.
Approved indications
- Chronic venous insufficiency
- Varicose veins
- Hemorrhoids
- Lymphedema
Common side effects
- Gastrointestinal upset
- Headache
- Dizziness
- Pruritus
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aesculus hippocastanum, and associations CI brief — competitive landscape report
- Aesculus hippocastanum, and associations updates RSS · CI watch RSS
- Fundação Educacional Serra dos Órgãos portfolio CI
Frequently asked questions about Aesculus hippocastanum, and associations
What is Aesculus hippocastanum, and associations?
How does Aesculus hippocastanum, and associations work?
What is Aesculus hippocastanum, and associations used for?
Who makes Aesculus hippocastanum, and associations?
Is Aesculus hippocastanum, and associations also known as anything else?
What drug class is Aesculus hippocastanum, and associations in?
What development phase is Aesculus hippocastanum, and associations in?
What are the side effects of Aesculus hippocastanum, and associations?
What does Aesculus hippocastanum, and associations target?
Related
- Drug class: All Herbal extract / Phlebotonic agent drugs
- Target: All drugs targeting Aescin (triterpene saponin); non-specific vascular and anti-inflammatory targets
- Manufacturer: Fundação Educacional Serra dos Órgãos — full pipeline
- Therapeutic area: All drugs in Cardiovascular / Vascular disorders
- Indication: Drugs for Chronic venous insufficiency
- Indication: Drugs for Varicose veins
- Indication: Drugs for Hemorrhoids
- Also known as: no other intervention names
- Compare: Aesculus hippocastanum, and associations vs similar drugs
- Pricing: Aesculus hippocastanum, and associations cost, discount & access